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Abstract
Risk assessment is a core skill in psychiatry. Risk prediction for suicide in schizophrenia is known to be complex. We undertook a systematic review of all
original studies concerning suicide in schizophrenia published since 2004. We found 51 data-containing studies (from 1281 studies screened) that met
our inclusion criteria, and ranked these by standardized quality criteria. Estimates of rates of suicide and risk factors associated with later suicide were
identified, and the risk factors were grouped according to type and strength of association with suicide. Consensus on the lifetime risk of suicide wasa
rate of approximately 5%. Risk factors with a strong association with later suicide included being young, male, and with a high level of education.
Illness-related risk factors were important predictors, with number of prior suicide attempts, depressive symptoms, active hallucinations and delusions,
and the presence of insight all having a strong evidential basis. A family history of suicide, and comorbid substance misuse were also positively
associated with later suicide. The only consistent protective factor for suicide was delivery of and adherence to effective treatment. Prevention of
suicide in schizophrenia will rely on identifying those individuals at risk, and treating comorbid depression and substance misuse, as well as providing
best available treatment for psychotic symptoms.
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Introduction
People with schizophrenia are known to die much earlier
(Saha et al., 2007) than expected. Up to 40% (Bushe et al.,
2010) of this excess premature mortality can be attributed to
suicide and unnatural deaths, with one authoritative review
(Palmer et al., 2005) estimating a lifetime suicide risk of 4.9%
for people with schizophrenia. Detection of those at risk is
clinically important, but risk prediction is known to be impre-
cise (Goldney, 2000).
An earlier systematic review (Hawton et al., 2005) of risk
factors for suicide in schizophrenia identiﬁed 29 high-quality
data-containing studies which were analysed for individual
risk factors. Hawton et al. (2005) found, perhaps unsurpris-
ingly, that many of the important risk factors for suicide in
schizophrenia were similar to those in the general population,
including mood disorder, recent loss, previous suicide
attempts, and drug misuse. However, some other factors
they identiﬁed as associated with high suicide risk in schizo-
phrenia, such as fear of mental disintegration, agitation or
restlessness,andpooradherencewithtreatment,arenotimme-
diately self-evident. Interestingly, Hawton et al. (2005) also
observed a reduced risk of suicide associated with the presence
of hallucinations. Since that time, Tiihonen et al. (2006) have
conﬁrmed,inanationwidefollow-upofindividualsdischarged
from hospital after a ﬁrst episode of schizophrenia, that not
taking any regular antipsychotic medication was associated
with a 12-fold increase in the relative risk of all-cause death
and a worrying 37-fold increase in death by suicide.
Risk assessment and risk management remain core skills
in clinical psychiatry. Since the 2005 review of Hawton
et al., which examined data published up until June 2004,
a large number of studies examining the rates and correlates
of suicide in schizophrenia have been produced. For exam-
ple, a recent non-systematic review by Carlborg et al. (2010)
found many of the risk factors listed above to be important,
as well as some disease-speciﬁc factors such as high suicide
risk in the ﬁrst year of illness and associations with a high
premorbid function and high IQ, but also noted the low
predictive speciﬁcity of these factors. We undertook a sys-
tematic review of all relevant studies published after June
2004 which provided new data on risk factors for suicide
in schizophrenia to better inform clinical practice. We
decided to only include studies likely to provide valid esti-
mates of risk factors, namely randomized controlled trials,
prospective and retrospective cohort studies, and case-
control studies. As part of our systematic review we decided
to rank the quality of the evidence, and hence assessed the
quality of the included studies, according to standardized
criteria.
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Search strategy and study eligibility
This systematic review included literature published between
June 2004 and January 2010. An electronic search on the fol-
lowing databases were carried out – EMBASE, PsychINFO
and OVID Medline (R). The subject headings used included:
(a) Catatonic Schizophrenia or Paranoid Schizophrenia or
Schizophrenia or Disorganized Schizophrenia or
Childhood Schizophrenia or schizophrenia.mp.,
Psychotic Disorders or schizoaﬀective psychosis.mp., and
(b) Suicide.mp. or Suicide, and
(c) Risk factor.mp. or Risk Factors, and
(d) Cohort Studies.mp. or Cohort Studies, Case Control
Studies.mp. or Case-Control Studies, Cohort
Analysis.mp. or Cohort Studies, Follow Up Studies.mp.
or Follow-Up Studies
The results of the search were screened for suitability inde-
pendently by both investigators. These studies were further
screened for eligibility based on the inclusion criteria:
(a) Literature published in English
(b) Case-control, cohort or follow-up studies
(c) Patient diagnosis of schizophrenia (including all sub-
types), psychosis and schizoaﬀective disorder
Data extraction
The shortlisted studies were then analysed and the following
data were extracted:
(a) Rate of suicide
(b) Socio-demographicinformation:age,gender,ethnicity,mar-
ital status, employment, education, social class, rural/urban
(c) Genetic/biological information: genetics, family history
of suicidal behaviour, biological markers
(d) Illness-related: age of onset, duration of disease, physical
illness, aﬀective disorder, thought disorder, depression,
psychopathology, insight
(e) Life events
(f) Previous suicide attempts/ideation
(g) Substance misuse/abuse/dependence: alcohol, smoking,
drugs
Quality of studies
The studies included in this systematic review were assessed
for quality. A score was given for study design: 4, randomized
controlled trials; 3, prospective cohort/follow-up study; 2, ret-
rospective cohort study; 1, case-control study. The studies
were also assessed for the following characteristics: explicit
aims, deﬁnition and size of population investigated, demo-
graphic details of subjects, explicit risk factors (if study
looked at risk factors), validity and reliability of methods,
response and drop-out rate speciﬁed, justiﬁcation of response
or drop-out rate, discussion of generalizability and discussion
of limitations. Each of these criteria was allocated 1 point and
the total score for each article was calculated. The six studies
which provided data on over 100 subjects and had the highest
quality scores were extracted and analysed in more detail, in
order to ascertain recurrent ﬁndings or themes.
Results
Data extraction
A total of 1281 articles were initially identiﬁed by the search
strategy. Of the 1281 studies identiﬁed, 12 papers were not
written in English and were therefore excluded from the
study. Some 71 papers (out of 1269) were shortlisted for
detailed analyses based on the abstracts; 20 of these papers
were not included as they did not address the objectives of
this study. A ﬁnal total of 51 studies were identiﬁed as rele-
vant to this study and were reviewed, as depicted in Figure 1.
All 51 papers were further analysed for risk factors for
suicide. The risk factors were grouped into six main categories
– Demographics, Illness-Related Factors, Insight, Suicide
Attempt/Ideation, Life Events and Genetics.
The following studies provided new data on the rates of
suicide in schizophrenia, which we have presented in Table 1.
The new data on risk factors for suicide in schizophrenia
were grouped into the six main themes noted above.
Individual demographic characteristics identiﬁed as risk fac-
tors for suicide are depicted in Table 2.
Risk factors for later suicide that were identiﬁed from sys-
tematic review and were related to the individual’s illness are
shown in Table 3.
Those familial or genetic characteristics studied, and eli-
cited by our systematic review, in individuals with schizophre-
nia who later committed suicide are contained in Table 4.
The other three speciﬁc domains of risk factors associated
with later suicide in people with schizophrenia are separated
below:
Total number of potentially
relevant papers=1281
Papers not meeting inclusion
criteria based on
abstract=1210
Papers retrieved for more
detailed evaluation=71
Final number of papers
included in the study=51
Figure 1. Flow chart showing the article-identification process.
82 Journal of Psychopharmacology 24(11)Suicide attempt/ideation. Of the 51 studies, 10 evaluated
history of suicide attempt/ideation as a risk factor for sui-
cide in patients with schizophrenia. All 10 studies identiﬁed
a positive correlation between suicide attempt/ideation and
suicide.
Substance abuse. Of the seven studies that looked into
substance misuse, four studies identiﬁed alcohol as a predis-
posing factor to increased suicides among patients with
schizophrenia, while three studies identiﬁed substance abuse
and one study identiﬁed smoking only. Only one study found
Table 1. Rates of suicide
Study Details of study Population Conclusion on suicide rates
Phillips et al.
(2004)
Retrospective observational study in
China. Data for 1995–99 were
extrapolated from data obtained
from 1993
Annual estimate of 4.25 million people
with schizophrenia and 284,614 total
suicides – of which 28,737 suicides
are by people with schizophrenia
10.1% of all suicides had schizophrenia.
Suicide rate in adults with schizo-
phrenia was 6.8/1000 people/year. RR
of suicide in those with schizophrenia
vs. those without is 23.8.
Silverton et al.
(2008)
43 year prospective longitudinal
Danish cohort study
208 children in ‘high-risk’ group (based
on mother’s diagnosis of schizophre-
nia), 11 committed suicide
Suicide was 14 times more likely in ‘high-
risk’ subjects diagnosed with schizo-
phrenia, compared with other mental
disorders or no mental disorders
Craig et al. (2006) Prospective cohort study. 5- and
10-year survival; absolute and
relative mortality rates among
first-admission patients with
psychotic disorder
235 patients with schizophrenia, 12
deaths due to all causes (four natural
deaths, seven unnatural death, one
unknown)
1.7% of all patients with schizophrenia
died by suicide
Ran et al.
(2007)
10-year prospective follow-up study
in rural China
500 patients with schizophrenia; 21 died
by suicide
Suicide rate was 477/100000 person-
years. SMR was 32.0. Risk of suicide
during the follow-up period was 4.5%.
Osborn et al.
(2008)
Retrospective cohort study in general
practices in UK from 1987–2002
46,136 patients with severe mental
illness (40.2% with schizophrenia)
included, matched with 300,426
controls
48 (0.26%) patients with schizophrenia
committed suicide; adjusted hazard
ratio¼7.00
Healy et al.
(2006)
Retrospective cohort study, North
Wales, UK. Compared lifetime
suicide rates in treated schizo-
phrenia between cohorts from
1875–1924 and 1994–1998
1875–1924: 594 patients with schizo-
phrenia, three suicides 1994–1998:
85 patients, four suicides
1875–1924: 16/100000 patient-years,
lifetime suicide rate of 0.46%
1994–1998: 752/100000
patient-years
Nordentoft et al.
(2004)
Case-control study using four Danish
longitudinal registers from
1981–1997
18,744 individuals committed suicide in
total, including 756 people with
schizophrenia
Suicide rates were found to decline from
1981–1997 by >50%. Incidence rate
ratio for suicide among patients with
schizophrenia was about 20 times
higher than the general population
Carlborg et al.
(2008)
Follow-up study in Sweden from
1973–2006
385 inpatients (153 men, 232 women)
with schizophrenia spectrum
psychoses
Rate of suicide during the follow-up
period was 6.8%. Incidence rate ratio
for suicide was 1.01
Bhatia et al.
(2006)
Retrospective cohort study with
Indian and American samples
460 Indians and 424 Americans More attempted suicides in US (205/424
in US vs. 107/460 in India cohorts)
Limosin et al.
(2007)
10-year prospective follow-up study
in France
3470 patients with schizophrenia, 141
suicides
Prevalence of suicide (global SMR) was
16.2. Mortality due to suicide espe-
cially high during the first 4 years of
follow-up
Barak et al.
(2004a)
10-year case-control study in Israel 692 elderly patients with schizophrenia,
30 patients attempted suicide
Rate of suicide attempts was  5%,
somewhat less than that reported for
younger patients
Laursen et al.
(2007)
Retrospective cohort study using two
population-based cohorts in
Denmark
Schizophrenia: 17,660 first admissions
and 3942 deceased. Schizoaffective:
4055 first admissions and 1261
deaths
Mortality rate ratio for suicide among
male and female patients with
schizophrenia was 34.51 and 58.81,
respectively. Schizophrenia highest
mortality rate ratio in the age groups
55–79 and 80þ.
RR, relative risk; SMR, standardised mortality ratio.
Hor and Taylor 83no diﬀerence in current substance abuse in those who com-
mitted suicide.
Life events. Only two studies looked at life events as a risk
factor for suicide. One of the studies looked at childhood
trauma and found that patients who committed suicide had
higher scores on the Childhood Trauma Questionnaire.
Another study found that those with schizophrenia had a
higher number of life events compared with a normal control
group, but people with schizophrenia who were suicidal had
fewer incidences of life events than those who were non-
suicidal.
Our systematic quality analysis of all available included
studies, using the scoring criteria noted above, yielded the
following results (Table 5):
The top six articles (percentage of maximum quality
score¼92%) were extracted for more detailed analysis.
Table 6 summarizes the details on methods, risk factors inves-
tigated and conclusions of each of these six studies.
Discussion
This systematic review included ﬁndings from 51 articles pub-
lished from June 2004 to January 2010. The main ﬁndings
from this review are as follows:
Suicide rate in schizophrenia
Studies so far have not come to an agreement on suicide rates
amongst patients with schizophrenia. The most widely cited
lifetime suicide rate is 10%, as estimated by a review by Miles
(1977). However, a recent study by Palmer et al. (2005) has
challenged this and has proposed that the lifetime suicide risk
in schizophrenia is approximately 4.9%. The current review
analysed contemporary data on suicide rates amongst
patients with schizophrenia, and we conclude that an accurate
estimated suicide rate is 579/100,000 person-years (477–680/
100,000 person-years). However, two other studies that inves-
tigated the proportion of people who died due to suicide who
also had schizophrenia reported a rate of 10.1% (Philips
et al., 2004) and 22.3% (Osborn et al., 2008), but proportion-
ate mortality should not be confused with lifetime risk.
It is perhaps not surprising that diﬀerent studies, using
diﬀerent populations and methodologies, return varying
estimates of the suicide rate in schizophrenia. Also, the
‘true’ suicide rate will ﬂuctuate over time, depending on
numerous complex variables including the period over
which the studies were carried out. In addition, many sui-
cides may be misclassiﬁed as ‘unnatural’ or ‘undetermined’
deaths. However, most studies seem to indicate that the
earlier consensus ﬁgure of 10% lifetime risk is an overesti-
mate (perhaps due to confusion with proportionate
Table 2. Patient demographics
Characteristic
Number
of studies Positive association No association
Conclusion on
risk factors
Age 10 7/10 identified young age as a predisposing risk
factor for increased suicide. One study noted
higher risk among patients >50y/o, and another
identified higher mean age of suicide among
females, but not in males
Young age not replicated in one study Young age
Gender 16 Two studies identified females having a higher risk
of suicide. Eleven studies found that males have
a higher risk of suicide
One study did not replicate findings on
male gender as a predisposing factor
for suicide. Two studies found no
difference in suicide between gender
Males
Ethnicity 2 One study showed that whites have higher suicide
rate, another found that being born in Sweden
predisposes to suicide
– Inconclusive
Marital status 3 Two studies found that being single predisposes
to suicide
One study found that there was no
difference in suicide
Single
Employment 3 Two studies found unemployment and inability to
work, respectively, as increasing risk of suicide.
One study identified minimal lost work potential
amongst the suicide group
– Unemployment
Education 6 All six studies identified higher levels of education
as a predisposing risk factor for suicide. One of
the studies only found this amongst the
Americans but not Indian subjects
– Higher levels
of education
Social class 4 One study identified higher suicide rate in those
from higher social class, and two studies identi-
fied homelessness and living alone, respectively,
as positive risk factors
One study found no difference in
economic status
Inconclusive
Rural/urban 1 Rural >urban by 3.18 times – Rural
84 Journal of Psychopharmacology 24(11)Table 3. Illness-related factors
Characteristic
Number of
studies Positive association No association Conclusion
Age of illness
onset
5 Three studies identified later age of onset as
a predisposing factor to increased sui-
cide. One study found younger age of
onset associated with suicide
One study found no difference Later age of onset
Duration of
illness
6 One study: 10 years, two studies: acute/
shorter duration of illness, two studies:
within first 3–5 years, one study: long
illness with exacerbations
– Inconclusive
Physical
illness
2 Both studies found positive correlation – Presence of physical illness
Affective
disorder
23 Seven studies found positive correlation
between affective disorders and increased
suicide. Fifteen studies identified a posi-
tive relationship between the presence of
depression and increased risk of suicide
Only one study found no difference in
level of depression between
attempters and non-attempters
Hopelessness, negative self-
thoughts. Presence of
depression
Psychotic
symptoms
16 Ten studies identified a positive correlation
between positive psychotic symptoms
and suicide in schizophrenia. Low levels
of negative symptoms also showed a
strong relationship with increased suicide
in three studies. Also positive: higher
level of baseline mental suffering (one
study) and mental disintegration and
agitation/restlessness (one study)
One study found no relationship
between suicide and lifetime
occurrence of hallucinations or
delusions. One study showed no
difference in suicidality by mean
number of negative symptoms
Increased positive symptoms,
particularly auditory hal-
lucinations and delusions,
but lower levels of nega-
tive symptoms
Insight 5 Four studies showed a positive correlation
between suicide and insight
One study found no difference in
suicide rates between groups with
insight and without
Presence of insight
Treatment 11 Two studies identified increased suicide risk
with current use of antidepressants and
being treated by male psychiatrists. One
study identified higher number of hospi-
talizations amongst those with who
committed suicide. Protective factors
include CBT, SGAs and
deinstitutionalization
One study found no difference in
suicide rates between those who
have been treated and those who
have not. Another study identified
no difference between groups
treated with CBTp, supportive
counselling or usual treatment
Inconclusive. Studies suggest
that second-generation
antipsychotics are
protective
CBT, cognitive behavioural therapy; SGA, second generation antipsychotic.
Table 4. Genetics
Characteristic
Number of
studies Positive association No association Conclusion
Family
history
4 Three studies identified a positive correla-
tion between family history of suicide
(behaviour/attempt) and suicide
One study found no difference Positive family history
Biological
markers
1 – No difference in CSF 5-HIAA levels and
CSF HVA levels between suicide
attempters and non-attempters
No association between CSF
5-HIAA and HVA levels,
and suicide
Genetics 2 One study: COMT Del Allele confers suscep-
tibility to suicide attempters. One study:
difference in mean ratios, with the ‘C’
alleles showing lower cDNA levels in the
suicide group; decreased total 5-HT2A
receptor mRNA in suicide victims
– Genes identified to be asso-
ciated with suicide – COMT
Del Allele,‘‘C’’ alleles and
5-HT2A receptor
Hor and Taylor 85mortality), with a lifetime risk of around 5% being more
representative, and compatible with various studies we
analysed (Barak et al., 2004a; Carlborg et al., 2008; Ran
et al., 2007; Limosin et al., 2007). This 5% ﬁgure remains
signiﬁcantly higher than the general population risk of
suicide.
We decided it would be clinically relevant and helpful to
classify the data on risk factors for suicide in schizophrenia,
Table 5. Quality analysis of all included original studies
Study Study design Percentage of maximum quality score (%)
Crumlish et al. (2005) Prospective Cohort Study 92
Fialko et al. (2006) Randomized Controlled Trial 92
Ran et al. (2007) Follow-Up/Cohort Study 92
Ran et al. (2009) Prospective Cohort Study 92
Montross et al. (2008) Randomized Controlled Trial 92
Ran et al. (2008) Prospective Cohort Study 92
Sevincok et al. (2007) Prospective Case-Control Study 85
Alara ¨isa ¨nen et al. (2006) Retrospective Cohort Study 85
Kuo et al. (2005) Follow-up Cohort Study 85
Pompili et al. (2009) Retrospective Cohort Study 85
Loas et al. (2009) Prospective Cohort Study 85
Bhatia et al. (2006) Retrospective Cohort Study 85
Limosin et al. (2007) Prospective Follow-up Study 85
McGirr et al. (2008) Retrospective Cohort Study 85
Bickley et al. (2006) Retrospective Cohort Study 85
Bateman et al. (2007) Randomized Controlled Trial 85
Silverton et al. (2008) Prospective Cohort Study 77
Carlborg et al. (2008) Follow-Up/Cohort Study 77
Tidemalm et al. (2008) Follow-Up/Cohort Study 77
Healy et al. (2006) Retrospective Cohort Study 77
Bertelsen et al. (2007) Randomized Controlled Trial 77
Laursen et al. (2007) Retrospective Cohort Study 77
Kelly et al. (2004) Retrospective Cohort Study 77
Haukka et al. (2008) Retrospective Cohort Study 77
Barak et al. (2004a) Retrospective Case-Control Study 77
Sinclair et al. (2004) Retrospective Case-Control Study 77
Reutfors et al. (2009) Retrospective Case-Control Study 77
Carlborg et al. (2009) Prospective Cohort Study 77
Preti et al. (2009) Prospective Cohort Study 77
Barak et al. (2004b) Retrospective Case-Control Study 77
Tarrier et al. (2006) Prospective Randomized Controlled Trial 77
Strauss et al. (2006) Retrospective Cohort Study 77
Altamura et al. (2007) Retrospective Cohort Study 77
Alara ¨isa ¨nen et al. (2009) Prospective Cohort Study 77
Rantanen et al. (2009) Follow-up Study 77
Niehaus et al. (2004) Case-Control Study 77
Ran et al. (2005) Retrospective Cohort Study 77
Lewine and Shriner (2009) Retrospective Cohort Study 69
Barak et al. (2008) Case-Control Study 69
Lee et al. (2009) Case-Control Study 69
McGirr et al. (2006) Case-Control Study 69
Osborn et al. (2008) Retrospective Cohort Study 69
Harkavy-Friedman et al. (2004) Retrospective Cohort Study 69
Roy (2005) Retrospective Case-Control Study 69
Li et al. (2008) Case-Control Study 69
De Luca et al. (2007) Case-Control Study 62
Bourgeois et al. (2004) Follow-Up/Cohort Study 62
De Luca et al. (2006) Case-Control Study 62
Karvonen et al. (2007) Retrospective Cohort Study 62
Phillips et al. (2004) Retrospective Cohort Study 62
Fennig et al. (2005) Case-Control Study 46
86 Journal of Psychopharmacology 24(11)according to the strength of the ﬁndings in the data reviewed.
Thus we produced Table 7, which summarizes those risk fac-
tors which have a strong association, and those with a weaker
(or negative) association for later suicide.
What have we learnt since 2005?
This systematic review has replicated some of the key ﬁndings
found in Hawton et al. (2005), including identifying a strong
association with later suicide in schizophrenia and earlier
depression, history of suicide attempts, and drug misuse.
Depression is one of the major risk factors for suicide
among individuals with schizophrenia. A randomized con-
trolled trial (OPUS Trial) (Bertelsen et al., 2007) investigated
suicidal thoughts and plans, depressive symptoms and drug
misuse in predicting suicidal attempts at 1- and 2-year follow-
up. This trial has shown that suicidal thoughts and plans,
previous suicide attempts and depressive symptoms are
among the strongest predictors of suicidality in patients pre-
senting with ﬁrst-episode psychosis. One of our top-scoring
articles (Fialko et al., 2006) used the Beck Depression
Inventory as a measure of the severity of depression and its
association with the risk of committing suicide. This study has
shown that the likelihood of patients with scores equal or
greater than 2 on Suicide Item (9) committing suicide
increases by seven-fold.
A history of prior suicide attempts elevates risk of com-
pleted suicide threefold according to both Reutfors et al.
(2009) and Sinclair et al. (2004), who found that individuals
who were admitted for an attempted suicide had the highest
risk (of all variables studied) of committing suicide (Odds
Ratio (OR)¼8.10).
In addition to drug misuse, we also identiﬁed alcohol
misuse as a key risk factor for suicide. The WHO Mental
Health Surveys (Nock et al., 2009) aimed to identify mental
disorders associated with suicidal behaviour and have shown
that alcohol (OR¼2.6) and drug (OR¼2.0) abuse or depen-
dency are strong predictive factors for suicide. However, one
of the studies included in this review (McGirr and Turecki,
2008) has shown that substance abuse does not increase risk
of suicide amongst patients with schizophrenia (alcohol abuse
and lifetime suicide risk OR¼0.29, drug abuse and lifetime
suicide risk OR¼0.94), although this study used data from
interviews with family members of the deceased patients,
which may not be the most accurate source of information.
Hawton et al. (2005) found that poor adherence to treat-
ment is associated with increased risk of suicide (OR¼3.75).
Some of the studies included in this review have shown that
individuals who underwent treatment had a smaller risk of
committing suicide (Barak et al., 2008; Preti et al., 2009;
Ran et al., 2007), but one particular study (Ran et al.,
2009) found no signiﬁcant diﬀerence between suicide rates
Table 6. Summary of the highest-quality studies of risk factors for suicide in schizophrenia
Study Title of paper Details of participants Conclusions re increased suicide risk
Crumlish et al. (2005) Early insight predicts depression and
attempted suicide after 4 years in
first-episode schizophrenia
101 participants, suicide
attempts was used as a
measurement
Insight is associated with increased risk
of suicide attempts. Insight is also
associated with depression
Fialko et al. (2006) Understanding suicidal ideation in psy-
chosis: findings from the
Psychological Prevention of Relapse
in Psychosis (PRP) trial
290 patients Younger age and male gender not repli-
cated Whites Anxiety, negative beliefs
and depression Auditory hallucina-
tions Daily alcohol consumption
Ran et al. (2007) Mortality in people with schizophrenia in
rural China: 10-year cohort study
500 patients >50 y/o, male gender and inability
to work associated with
increased risk
Age of onset>45 y/o, duration of dis-
ease 10 years, physical illness
Reduced risk with treatment
Ran et al. (2009) Differences in mortality and suicidal
behaviour between treated and never-
treated people with schizophrenia in
rural China
500 patients, 132 never
received antipsychotic and
368 reported having
received antipsychotic
treatment
Suicide rates were not significantly dif-
ferent between treated and non-
treated schizophrenic patients.
Overall mortality rates in patients are
high when compared with general
population (>6.5 times)
Montross et al. (2008) Suicidal ideation and attempts among
middle-aged and older patients with
schizophrenia spectrum and concur-
rent subsyndromal depression.
132 patients Male gender Hopelessness,
depression, higher PANSS
general psychopathology
subscale scores
History of suicidal ideation
Ran et al. (2008) Mortality of geriatric and younger
patients with schizophrenia in the
community
500 patients Patients from the younger age group had
higher suicide rates
PANSS, positive and negative syndrome scale
Hor and Taylor 87between the treated and non-treated group, although Ran
et al. (2009) found that the non-treated group had more
severe symptoms.
An interesting ﬁnding in this study is the association
between the presence of positive symptoms, in particular
auditory hallucinations and delusions, and an increased risk
of suicide among patients with schizophrenia. This is in con-
trast with the ﬁndings reported by Hawton et al. (2005). This
diﬀerence may be due to the heterogeneity of the data in
Hawton et al. (2005) which resulted in a relatively weak asso-
ciation between hallucinations and reduced risk of suicide.
While our study has identiﬁed a positive association, further
studies are required to conﬁrm this.
Conventional wisdom suggests that increased risk of sui-
cide in schizophrenia is associated with young age. However,
some of the studies (Fialko et al., 2006; Kuo et al. 2005; Ran
et al., 2007; Reutfors et al., 2009) included in this review have
challenged this association, with both Reutfors et al. (2009)
and Kuo et al. (2005) ﬁnding that a later age of illness onset is
associated with an increased risk of suicide. Ran et al. (2007)
identiﬁed that age (>50 years old, hazard ratio¼4.8) and age
at illness onset (>45 years old, hazard ratio¼9.2) are inde-
pendent predictors of mortality in the population studied, but
this study did not deﬁne the causes of death or investigate
speciﬁc predictors of suicide. The diﬀerence in conclusions
about age as a risk factor for suicide in patients with schizo-
phrenia may be a result of the design of the study, with
shorter-term studies having a tendency of identifying younger
patients as a higher risk group. Further studies are needed to
identify if older age and later age of onset are indeed strong
predictors of suicide, and such studies should take into
account the severity of psychotic symptoms, chronicity of ill-
ness, and other co-morbidities including aﬀective disorders.
Until then, the weight of evidence supports a younger age as a
risk factor.
Some of the risk factors identiﬁed in this systematic review
may be similar or may oppose those observed in the general
population, as Agerbo (2007) has pointed out. However, for
the purposes of this study, the risk factors identiﬁed are in
relation to patients with schizophrenia and are not compared
with risk factors in the general population. This systematic
review looked at studies that identiﬁed either suicide or sui-
cide ideation as an outcome. This may potentially aﬀect our
ﬁndings, although a history of suicide attempt or ideation has
a strong positive correlation with completed suicide among
patients with schizophrenia. Therefore, we feel that inclusion
of studies with suicide ideation or attempt as an outcome in
this study is justiﬁed.
Limitations
We did not attempt to perform a meta-analysis, which would
allow a quantitative analysis of predictors of suicide for
schizophrenia. However, diﬀering study designs of studies
included in this systematic review mean that not all data are
amenable to meta-analysis. We only reviewed papers that
were published in English.
Conclusions
Since an earlier systematic review conducted by Hawton et al.
(2005), there have been numerous studies published concern-
ing suicide in schizophrenia. We included 51 new data-
containing studies in this critical systematic review, and
found that the factors with the strongest association with
later suicide (in schizophrenia) included being young and
male, with a higher level of education. Illness-related factors
were also important predictors, namely depressive symptoms,
a history of suicide attempts, active hallucinations (contrary
to Hawton et al., 2005) and delusions, the presence of insight,
Table 7. Summary of risk factors associated with suicide in schizophrenia
Risk factor Strong association with suicide Weak association with suicide
Demographic
factors
Young, male, unemployment, with higher levels of
education
Single (not married), rural
Illness-related
factors
Presence of depression, hopelessness, negative self-
thoughts, anxiety, insomnia, self-devaluation, low self-
esteem, guilty thoughts and PTSD
Treatment (in particular, second-generation antipsychotic)
may be a protective factor against suicide
Increased positive symptoms, in particular auditory hallu-
cinations and delusions; low negative symptoms; higher
level of mental suffering at baseline; mental disinte-
gration and agitation/motor restlessness
Later age of onset
The impact of duration of disease on suicide risk is
inconclusive
Presence of insight
Presence of physical illnesses
Genetics Positive family history
Previous suicide
attempt/ideation
Strong correlation with history of suicide attempt/ideation
Substance abuse Alcohol and drug abuse Smoking
Life events Potentially increased risk with history of increased
childhood trauma
PTSD, post-traumatic stress disorder
88 Journal of Psychopharmacology 24(11)and comorbid chronic physical illness. Lastly, a family history
of suicide and co-existing alcohol and drug misuse were also
factors with a strong association with later suicide. Adequate
treatment for schizophrenia and related comorbid problems
was the only protective factor identiﬁed.
Prevention of suicide in schizophrenia would thus rely on
identifying those individuals with the risk factors noted
above, and actively treating any comorbid depressive illness
and positive psychotic symptoms, as well as addressing any
co-existent substance misuse. However, suicide prediction in
those with schizophrenia is complex, and eﬀorts at prevention
should also focus on optimizing adherence to medication, and
possible earlier use of clozapine, as the only antipsychotic
medication with demonstrated eﬃcacy (and a licence in the
USA) for the management of suicidality in schizophrenia.
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